Annexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice

Sisi He1,2, Xuefeng Li1,2, Rongpeng Li2

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, P. R. China.

Plos Pathogens
|July 9, 2016
PubMed

Insights

Annexin A2 (AnxA2) inhibits sepsis inflammation by regulating reactive oxygen species (ROS) and IL-17 signaling. AnxA2 deficiency worsens sepsis outcomes, highlighting its protective role in this complex disease.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathophysiology

Background:

  • Sepsis is a life-threatening condition characterized by dysregulated inflammation and organ dysfunction.
  • Limited therapeutic options necessitate a deeper understanding of sepsis molecular pathogenesis.
  • Annexin A2 (AnxA2) is a multi-compartmental protein with an uncharacterized role in inflammatory diseases.

Purpose of the Study:

  • To investigate the novel role of Annexin A2 (AnxA2) in regulating inflammatory responses during sepsis.
  • To elucidate the molecular mechanisms by which AnxA2 influences sepsis pathophysiology, focusing on reactive oxygen species (ROS) and IL-17 signaling.

Main Methods:

  • Utilized cecal ligation and puncture (CLP) sepsis models in wild-type and anxa2-/- mice.
  • Employed site-directed mutagenesis to identify critical residues in AnxA2 for ROS regulation.
  • Used CRISPR/Cas9 gene editing to deplete IL-17 in anxa2-/- mice to assess its role in sepsis.

Main Results:

  • anxa2-/- mice exhibited exacerbated inflammation, increased neutrophil infiltration, and reduced survival compared to controls.
  • AnxA2 deficiency was associated with elevated levels of reactive oxygen species (ROS) and IL-17A.
  • Cysteine 9 of AnxA2 was identified as crucial for ROS level regulation.
  • Depletion of IL-17A ameliorated inflammation and improved survival in anxa2-/- mice, indicating ROS-mediated IL-17A elevation drives sepsis pathology.

Conclusions:

  • Annexin A2 (AnxA2) plays a critical inhibitory role in the inflammatory response during polymicrobial sepsis.
  • The AnxA2-ROS-IL-17 signaling axis is a key regulator of sepsis pathophysiology.
  • Targeting the AnxA2-ROS-IL-17 pathway may offer novel therapeutic strategies for sepsis treatment.